Chinese english Germany Japanese Korea

tert-butyl 4-(6-hydroxypyridin-2-yl)piperidine-1-carboxylate

tert-butyl 4-(6-hydroxypyridin-2-yl)piperidine-1-carboxylate Struktur
1448682-17-4
CAS-Nr.
1448682-17-4
Englisch Name:
tert-butyl 4-(6-hydroxypyridin-2-yl)piperidine-1-carboxylate
Synonyma:
tert-butyl 4-(6-hydroxypyridin-2-yl)piperidine-1-carboxylate;tert-Butyl 4-(6-oxo-1,6-dihydropyridin-2-yl)piperidine-1-carboxylate;1-Piperidinecarboxylic acid, 4-(1,6-dihydro-6-oxo-2-pyridinyl)-, 1,1-dimethylethyl ester
CBNumber:
CB04865843
Summenformel:
C15H22N2O3
Molgewicht:
278.35
MOL-Datei:
1448682-17-4.mol
Request For Quotation

tert-butyl 4-(6-hydroxypyridin-2-yl)piperidine-1-carboxylate Eigenschaften

Siedepunkt:
464.4±45.0 °C(Predicted)
Dichte
1.150±0.06 g/cm3(Predicted)
pka
11.68±0.10(Predicted)

Sicherheit

tert-butyl 4-(6-hydroxypyridin-2-yl)piperidine-1-carboxylate Chemische Eigenschaften,Einsatz,Produktion Methoden

tert-butyl 4-(6-hydroxypyridin-2-yl)piperidine-1-carboxylate Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

tert-butyl 4-(6-hydroxypyridin-2-yl)piperidine-1-carboxylate Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 5)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Combiphos (Shanghai) Biological Technology Co., Ltd. 021-65232103 17602124823
 combiphos@vip.qq.com China 29909 58
Shanghai Haohong Pharmaceutical Co., Ltd. 4008210725 4008210725
 malulu@leyan.com China 54986 58
Jinan Xinhongtai Chemical Co. LTD 13000000000
 jnxinhongtai@126.com China 19528 58
Beijing Taihe Jingming Pharmaceutical Technology Co., Ltd. 15011440205
 chem_w@163.com China 304 58
Beijing Taihe Jingming Pharmaceutical Technology Co., Ltd 15011440205
 2053813258@qq.com China 357 58
  • tert-butyl 4-(6-hydroxypyridin-2-yl)piperidine-1-carboxylate
  • tert-Butyl 4-(6-oxo-1,6-dihydropyridin-2-yl)piperidine-1-carboxylate
  • 1-Piperidinecarboxylic acid, 4-(1,6-dihydro-6-oxo-2-pyridinyl)-, 1,1-dimethylethyl ester
  • 1448682-17-4
Copyright 2019 © ChemicalBook. All rights reserved